Difficulty: Medium
Average Score: 68%
Practice
Which of the following is not a parasympatholytic drug:
Correct answer
D
Rationale
In this question regarding parasympatholytic drugs, it is crucial to understand the pharmacological action of each option to determine the correct answer.
The correct answer is D) Edrophonium. Edrophonium is a reversible acetylcholinesterase inhibitor used in the diagnosis of myasthenia gravis, and it is not a parasympatholytic drug. It functions by inhibiting the breakdown of acetylcholine, leading to increased muscle strength.
A) Atropine is a classic example of a parasympatholytic drug. It blocks acetylcholine receptors in the parasympathetic nervous system, resulting in decreased vagal tone and subsequent effects such as increased heart rate.
B) Propantheline is another parasympatholytic drug that acts by inhibiting muscarinic acetylcholine receptors, leading to decreased activity of the parasympathetic nervous system.
C) Pirenzepine is also a parasympatholytic drug that selectively blocks M1 muscarinic receptors, primarily used in the treatment of peptic ulcers.
In an educational context, understanding the classification and mechanisms of action of drugs affecting the peripheral nervous system is vital for healthcare professionals. It allows for the safe and effective use of these medications in clinical practice, as well as the ability to differentiate between various drug classes for specific patient scenarios.
The correct answer is D) Edrophonium. Edrophonium is a reversible acetylcholinesterase inhibitor used in the diagnosis of myasthenia gravis, and it is not a parasympatholytic drug. It functions by inhibiting the breakdown of acetylcholine, leading to increased muscle strength.
A) Atropine is a classic example of a parasympatholytic drug. It blocks acetylcholine receptors in the parasympathetic nervous system, resulting in decreased vagal tone and subsequent effects such as increased heart rate.
B) Propantheline is another parasympatholytic drug that acts by inhibiting muscarinic acetylcholine receptors, leading to decreased activity of the parasympathetic nervous system.
C) Pirenzepine is also a parasympatholytic drug that selectively blocks M1 muscarinic receptors, primarily used in the treatment of peptic ulcers.
In an educational context, understanding the classification and mechanisms of action of drugs affecting the peripheral nervous system is vital for healthcare professionals. It allows for the safe and effective use of these medications in clinical practice, as well as the ability to differentiate between various drug classes for specific patient scenarios.